Bullfrog AI (BFRG) Competitors $1.81 -0.09 (-4.74%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.82 +0.01 (+0.83%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. INZY, PMVP, OKUR, OCX, ANEB, TNYA, GANX, ALTS, APLT, and IKNAShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Inozyme Pharma (INZY), PMV Pharmaceuticals (PMVP), OnKure Therapeutics (OKUR), OncoCyte (OCX), Anebulo Pharmaceuticals (ANEB), Tenaya Therapeutics (TNYA), Gain Therapeutics (GANX), Janone (ALTS), Applied Therapeutics (APLT), and Ikena Oncology (IKNA). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Inozyme Pharma PMV Pharmaceuticals OnKure Therapeutics OncoCyte Anebulo Pharmaceuticals Tenaya Therapeutics Gain Therapeutics Janone Applied Therapeutics Ikena Oncology Inozyme Pharma (NASDAQ:INZY) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation, community ranking and earnings. Does the MarketBeat Community prefer INZY or BFRG? Inozyme Pharma received 60 more outperform votes than Bullfrog AI when rated by MarketBeat users. CompanyUnderperformOutperformInozyme PharmaOutperform Votes6088.24% Underperform Votes811.76%Bullfrog AIN/AN/A Does the media favor INZY or BFRG? In the previous week, Bullfrog AI had 1 more articles in the media than Inozyme Pharma. MarketBeat recorded 3 mentions for Bullfrog AI and 2 mentions for Inozyme Pharma. Inozyme Pharma's average media sentiment score of 1.61 beat Bullfrog AI's score of 1.08 indicating that Inozyme Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inozyme Pharma 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bullfrog AI 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend INZY or BFRG? Inozyme Pharma currently has a consensus price target of $14.56, suggesting a potential upside of 1,363.31%. Given Inozyme Pharma's stronger consensus rating and higher probable upside, equities research analysts plainly believe Inozyme Pharma is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inozyme Pharma 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, INZY or BFRG? Bullfrog AI has higher revenue and earnings than Inozyme Pharma. Bullfrog AI is trading at a lower price-to-earnings ratio than Inozyme Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInozyme PharmaN/AN/A-$71.17M-$1.63-0.61Bullfrog AI$60K284.02-$5.36M-$0.86-2.10 Which has more risk and volatility, INZY or BFRG? Inozyme Pharma has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.32, suggesting that its stock price is 68% less volatile than the S&P 500. Do insiders & institutionals have more ownership in INZY or BFRG? 88.3% of Inozyme Pharma shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 11.2% of Inozyme Pharma shares are held by company insiders. Comparatively, 33.9% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is INZY or BFRG more profitable? Inozyme Pharma's return on equity of -88.42% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Inozyme PharmaN/A -88.42% -57.02% Bullfrog AI N/A -141.39%-124.63% SummaryInozyme Pharma beats Bullfrog AI on 10 of the 15 factors compared between the two stocks. Remove Ads Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.04M$6.92B$5.65B$8.06BDividend YieldN/A2.72%4.57%4.01%P/E Ratio-2.137.2023.1419.03Price / Sales284.02226.01385.7893.17Price / CashN/A65.6738.1634.64Price / Book4.216.476.934.33Net Income-$5.36M$141.90M$3.20B$247.06M7 Day Performance2.84%-3.20%-2.30%-0.37%1 Month Performance-13.40%-5.64%2.86%-3.85%1 Year Performance-43.61%-7.47%10.66%1.27% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI1.3961 of 5 stars$1.81-4.7%N/A-47.7%$17.04M$60,000.00-2.134Upcoming EarningsShort Interest ↓Positive NewsGap DownINZYInozyme Pharma3.7647 of 5 stars$1.02+2.0%$14.56+1,327.0%-86.5%$65.53MN/A-0.6550Positive NewsPMVPPMV Pharmaceuticals2.3005 of 5 stars$1.26flat$5.50+336.5%-30.3%$65.44MN/A-1.2650OKUROnKure Therapeutics2.6687 of 5 stars$4.82+4.6%$34.33+612.3%N/A$64.76MN/A-0.40N/AGap UpOCXOncoCyte2.5537 of 5 stars$3.70-1.1%$4.42+19.4%+8.1%$64.58M$709,000.000.00120Earnings ReportAnalyst ForecastShort Interest ↑ANEBAnebulo Pharmaceuticals2.9872 of 5 stars$1.56-8.8%$8.00+412.8%-49.6%$64.09MN/A-5.574Short Interest ↓Positive NewsGap DownHigh Trading VolumeTNYATenaya Therapeutics4.1274 of 5 stars$0.73+4.4%$6.25+756.2%-86.6%$63.94MN/A-0.51110Short Interest ↓Analyst RevisionGap DownGANXGain Therapeutics3.23 of 5 stars$2.40+13.7%$8.20+241.7%-44.5%$63.66M$50,000.00-2.1820Earnings ReportHigh Trading VolumeALTSJanoneN/A$4.52-2.6%N/AN/A$63.59M$7.11M0.00170Short Interest ↓APLTApplied Therapeutics4.2755 of 5 stars$0.55+6.4%$6.10+1,016.4%-92.1%$63.58M$-212,000.00-0.3430Upcoming EarningsPositive NewsIKNAIkena Oncology2.9701 of 5 stars$1.31-2.2%$3.00+129.0%-4.3%$63.22M$659,000.00-1.0770Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Inozyme Pharma Competitors PMV Pharmaceuticals Competitors OnKure Therapeutics Competitors OncoCyte Competitors Anebulo Pharmaceuticals Competitors Tenaya Therapeutics Competitors Gain Therapeutics Competitors Janone Competitors Applied Therapeutics Competitors Ikena Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BFRG Stock Free BFRG Stock Alerts